3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases. Race Reporting: doi.org/10.1038/s41391-021-00361-0 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Episode metadata supplied by the publisher feed · Published May 17, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe

0:00 25:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 25 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on May 17, 2021.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!